Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 11, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • India
  • Page 6

Category: India

Weekly Biotech News of India

  • BiotechToday
  • India
  • World

Assessing the Changing Treatment Landscape in Triple-Negative Breast Cancer !

bioxone October 8, 2020October 8, 2020 2

Sagnik Nag, Amity University Kolkata Breast cancer is among the second largest cause of deaths among women related to cancer. The development of breast cancer is a multi-step process that involves numerous cell types and its treatment remains shrouded with many challenges. Triple-negative breast cancers (TNBC) is accounted for 10-15% of all breast cancers.  Triple-negative breast […]

Read More
  • BiotechToday
  • India
  • World

COVID-19 or flu? Which one to control first?

bioxone October 7, 2020October 7, 2020

Camelia Bhattacharyya, Amity University Kolkata Amidst the pandemic prevailing recently due to the SARS-CoV-2, there is something which still can’t be ignored, the flu which leads to thousands of deaths in the US and infects about 11% of the population each year according to CDC. With the arrival of the flu along with the COVID-19, […]

Read More
  • BiotechToday
  • India

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

bioxone October 7, 2020October 7, 2020

Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]

Read More
  • BiotechToday
  • India
  • World

Organic Pesticides- a boon or a bane?

bioxone October 5, 2020October 5, 2020 1

Shrayana Ghosh, Amity University Kolkata To ensure a stable food supply, it is necessary to protect crops against pests and diseases. Roughly 95% of food comes from organic cultivation, using chemical pesticides to preserve the quality of the crops. But organic pesticides are increasingly being pursued as an option as well. Some organic pesticides contain […]

Read More
  • BiotechToday
  • India
  • World

Pet bearded dragons droppings cause Salmonella outbreak: Question is are they safe?

bioxone October 4, 2020October 5, 2020

Prama Ghosh, Amity University Kolkata 13 people from 8 states have been infected with the outbreak strain of Salmonella muenster linked to bearded dragons, as of 25th September, according to the latest information released from the Centers for Disease Control and Prevention (CDC).  Pet bearded dragons are likely the source of this outbreak as shown […]

Read More
  • BiotechToday
  • India
  • World

Here’s how COVID-19 vaccine BNT162b1 produces human antibody and helper T-cell responses

bioxone October 4, 2020October 4, 2020

Ayooshi Mitra, Amity University Kolkata To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified […]

Read More
  • BiotechToday
  • India
  • World

Can high systemic inflammation biomarkers during puberty result in breast cancer?

bioxone October 4, 2020October 3, 2020

Devyani Goswami, Amity University Kolkata Breast cancer has become one of the common diseases affecting both men and women worldwide, though most common in women as of yet. There are multifactorial reasons for the formation of breast cancer, depending on the type of breast cancer. A common trait observed in all cancer patients is an […]

Read More
  • BiotechToday
  • India
  • World

Can a Nose Swab Test For COVID-19 Pierce through your Brain? – It’s NO.

bioxone October 3, 2020October 3, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA A recently reported case was taken where a 40-year-old US women’s brain lining was punctured after her nasal swab test for COVID-19 which ultimately lead to the leakage of the brain fluid through her nose, and eventually putting her at risk of life-threatening infection. The patient had an undetected scarce […]

Read More
  • BiotechToday
  • India
  • World

HIV (Human Immunodeficiency Virus)- can be cured

bioxone October 3, 2020October 3, 2020

Sambit Majumdar, Amity University Kolkata HIV i.e. Human Immunodeficiency Viruses are two species of Lentivirus that infect humans. It is a virus that attacks the cells in the immune system. This virus destroys a type of white blood cell in the immune system called a T helper cell, also mention as a CD4 cell. This […]

Read More
  • BiotechToday
  • India
  • World

Does an Irregular menstrual cycle come along with a risk of premature deaths?

bioxone October 3, 2020October 3, 2020 2

Arjama Roy, Amity University Kolkata A woman’s menstrual cycle is usually for 28 days. However, this may vary from person to person.  If the length of the menstrual cycle is more than 35 days, or if the duration varies, then we call it irregular periods. It may happen due to hormonal imbalance, changes in contraception, […]

Read More

Posts navigation

1 2 3 4 5 6 7 8 9 10

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy